Earlier this month Pfizer surprized investors with it's report. The company said its bottom line came in at $4.16 billion, or $0.67 per share. This was higher than $3.20 billion, or $0.51 per share, in last year's first quarter. Analysts had expected the company to earn $0.55 per share, according figures compiled by Thomson Reuters. If we try not to jump to conclusions and check technical picture, one can notice a healthy rising "flaggish" trend, which looks just perfect to me. I have been long PFE for a few years already and was recently thinking of dumping the stock, but now I feel that upside is still there. So I HOLD Pfizer) $PFE, Pfizer, Inc. / 1440